Department of Anesthesia, University of California, San Francisco at San Francisco General Hospital, San Francisco, California 94110, USA.
Respir Care. 2010 May;55(5):617-22.
We report a complicated case of acute respiratory distress syndrome (ARDS) from severe sepsis, in which we measured the ratio of physiologic dead space to tidal volume (V(D)/V(T)) with volumetric capnography prior to, during, and after therapy with human recombinant activated protein C. Previous studies hypothesized that early in ARDS, elevated V(D)/V(T) primarily reflects increased alveolar V(D), probably caused by pronounced thrombi formation in the pulmonary microvasculature. This may be particularly true when severe sepsis is the cause of ARDS. We repeatedly measured V(D)/V(T) in a 29-year-old man with sepsis-induced ARDS over the course of activated protein C therapy. Treatment with activated protein C resulted in a pronounced reduction in V(D)/V(T), from 0.55 to 0.27. Alveolar V(D) decreased from 165 mL to 11 mL (93% reduction). Activated protein C was terminated at 41 h because of gastrointestinal bleeding. When the measurement was repeated 29 h after therapy was discontinued, V(D)/V(T) had increased modestly, to 0.34, whereas alveolar V(D) had increased to 71 mL, or 43% of the pre-activated-protein-C baseline measurement. Alveolar V(T) rose from 260 mL to 369 mL and decreased slightly after termination of activated protein C (336 mL). Over the course of activated protein C therapy there was a persistent decrease in alveolar V(D) and increase in alveolar V(T), even while positive end-expiratory pressure was reduced and respiratory-system compliance decreased. Thus, improved alveolar perfusion persisted despite signs of alveolar de-recruitment. This suggests that activated protein C may have reduced microvascular obstruction. This report provides indirect evidence that microvascular obstruction may play an important role in elevated V(D)/V(T) in early ARDS caused by severe sepsis.
我们报告了一例由严重败血症引起的急性呼吸窘迫综合征(ARDS)的复杂病例,在使用人重组活化蛋白 C 治疗前后,通过容积二氧化碳图测量了生理死腔与潮气量之比(V(D)/V(T))。先前的研究假设,在 ARDS 的早期,升高的 V(D)/V(T)主要反映了肺泡死腔的增加,可能是由于肺微血管中明显的血栓形成所致。当严重败血症是 ARDS 的原因时,这种情况可能更为真实。我们在一名因败血症引起的 ARDS 的 29 岁男性患者中,在接受活化蛋白 C 治疗期间反复测量了 V(D)/V(T)。使用活化蛋白 C 治疗导致 V(D)/V(T)明显降低,从 0.55 降至 0.27。肺泡死腔从 165 mL 降至 11 mL(93%减少)。由于胃肠道出血,在 41 小时后停用了活化蛋白 C。在治疗停止后 29 小时再次测量时,V(D)/V(T)略有增加,达到 0.34,而肺泡死腔增加到 71 mL,或达到治疗前基线测量值的 43%。肺泡潮气量从 260 mL 增加到 369 mL,在停用活化蛋白 C 后略有下降(336 mL)。在使用活化蛋白 C 治疗过程中,尽管呼气末正压降低和呼吸系统顺应性降低,但肺泡死腔持续减少,肺泡潮气量增加。因此,尽管肺泡复张迹象存在,但肺泡灌注仍得到改善。这表明活化蛋白 C 可能减少了微血管阻塞。本报告提供了间接证据,表明微血管阻塞可能在严重败血症引起的早期 ARDS 中升高的 V(D)/V(T)中起重要作用。